Chugai Pharmaceutical Co. Ltd Financials

Market Capitalization ¥10.943 Trillion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	28.25
Forward PE	28.19
Price to Sales TTM	¥9.58
Price to Book MRQ	¥6.07
Enterprise to Revenue	8.84
Enterprise to EBITDA	17.81

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-06-30
Profit Margin	33.87%
Operating Margin	50.81%
Return on Assets TTM	17.37%
Return on Equity TTM	23.20%

Income Statement

Revenue TTM	¥1,142,350,020,608
Revenue per Share TTM	¥694.27
Quarterly Revenue Growth	22.40%
Gross Profit TTM	¥698,061,000,000
EBITDA	¥488,374,000,000
Net Income to Common TTM	¥386,963,996,672
Diluted EPS TTM	¥235.41
Quarterly Earnings Growth YoY	41.20%

Balance Sheet

Total Cash MRQ	¥845,317,996,544
Total Cash per Share MRQ	¥513.71
Total Debt MRQ	¥
Total Debt to Equity MRQ	0.00
Current Ratio MRQ	5.89
Book Value per Share MRQ	¥1094.71

Cash Flow

Operating Cash Flow TTM	¥419,416,014,848
Levered Free Cash Flow TTM	¥290,696,265,728

4519 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,645,510,016
Float Shares	639,512,613
Avg 10 Volume	2,043,990
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	59.91%
% Held by Institutions	18.88%

Stock Price Summary

Beta	0.50
Fifty Two Week Low	¥4572.00
Fifty Two Week High	¥7869.00
Fifty Two Week Change	16.19%
Day 50 MA	¥6917.52
Day 200 MA	¥6152.07

Dividends and Splits

Forward Annual Dividend Rate	¥82.00
Forward Annual Dividend Yield	1.26%
Trailing Annual Dividend Rate	¥81.00
Trailing Annual Dividend Yield	1.25%
Payout Ratio	34.45%
Dividend Date
Ex Dividend Date	2024-12-27
Last Split Factor
Last Split Date	2020-06-29